CA
NZ
UK
AU
IND
US
The company’s platform logged 0.8 million visits, while subscription revenue reached $25.7 million, nearly half of total revenue. This momentum positions Amwell to meet its goal of positive cash flow in the fourth quarter, a milestone that could further boost the stock.
The company’s platform logged 0.8 million visits, while subscription revenue reached $25.7 million, nearly half of total revenue. This momentum positions Amwell to meet its goal of positive cash flow in the fourth quarter, a milestone that could further boost the stock.
Total revenues for the quarter reached $10.1 billion, marking a 10% rise compared to the same quarter the previous year. This strong performance is attributed partly to significant growth in product sales, showcasing Amgen's resilience and capacity to meet market demands. As the company …
Ardent Health (NYSE: ARDT) reported earnings per share of $0.12 for the quarter ended June 30, falling short of the $0.18 consensus. Investors now face a clash between a strong price rally and weaker-than‑expected earnings, a dynamic that could reshape valuation multiples in the …
This increase aligns with the company’s strategic focus on expanding its innovative product offerings, particularly the siRNA therapy REDEMPLO. The latest earnings slightly exceeded analyst expectations, with the company reporting an EPS of $-1.36, just off the $-1.35 consensus estimate. This financial performance highlights …
Arvinas, Inc. (NASDAQ: ARVN) reported a stellar earnings per share of $2.58 for the quarter ending June 30, 2026, a significant upside from the consensus estimate of $-0.38. This performance highlights the progress Arvinas has made with its drug development initiatives, including the key …
Alphatec Holdings Inc. (NASDAQ: ATEC) faces increasing scrutiny as it prepares for its upcoming earnings report. ATEC shares have dropped 51.2% year-to-date, weighing heavily on investor sentiment. The stock's recent performance shows a slight uptick, gaining 8.5% over the past month, which may indicate …
Alphatec Holdings, Inc. (NASDAQ: ATEC) reported total revenue of $214 million for the quarter ending June 30, 2026, reflecting a strong 15% increase year-over-year. This performance surpasses the company's adjusted expectations; for the previous quarter, Alphatec had an EPS of $0.00 against a consensus …
AdaptHealth Corp. (NASDAQ: AHCO) announced net revenue of $740.3 million for the second quarter, reflecting a 12.7% increase from $657.1 million in the same period last year. Despite this growth, the company reported a net loss of $145.3 million, sharply contrasting with the previous …
This increase translates to a strong adjusted revenue growth of 17% year-over-year. Acadia's earnings per share (EPS) came in at $0.18, significantly outperforming the consensus estimate of $0.06. Strong performance from both its primary products, NUPLAZID and DAYBUE, has bolstered investor confidence, as indicated …
Please wait processing your request...